FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281620148> ?p ?o ?g. }

• W4281620148 endingPage "e376" @default.
• W4281620148 startingPage "e369" @default.
• W4281620148 abstract "Aim To determine the efficacy of preoperative chemoradiotherapy as per the CROSS protocol for oesophageal/gastroesophageal junction cancer (OEGEJC), when expanded to patients outside of the inclusion/exclusion criteria defined in the original clinical trial. Materials and methods Data were collected retrospectively on 229 OEGEJC patients referred for curative-intent preoperative chemoradiotherapy. Outcomes including pathological complete response (pCR), overall survival (OS), cancer-specific survival and recurrence-free survival (RFS) of patients who met CROSS inclusion criteria (MIC) versus those who failed to meet criteria (FMIC) were determined. Results In total, 42.8% of patients MIC, whereas 57.2% FMIC; 16.6% of patients did not complete definitive surgery. The MIC cohort had higher rates of pCR, when compared with the FMIC cohort (33.3% versus 20.6%, P = 0.039). The MIC cohort had a better RFS, cancer-specific survival and OS compared with the FMIC cohort (P = 0.006, P = 0.004 and P = 0.009, respectively). Age >75 years and pretreatment weight loss >10% were not associated with a poorer RFS (P = 0.541 and 0.458, respectively). Compared with stage I–III patients, stage IVa was associated with a poorer RFS (hazard ratio (HR) = 2.158; 95% confidence interval (CI) = 1.339–3.480, P = 0.001). Tumours >8 cm in length or >5 cm in width had a trend towards worse RFS (HR = 2.060; 95% CI = 0.993–4.274, P = 0.052). Conclusion Our study showed that the robust requirements of the CROSS trial may limit treatment for patients with potentially curable OEGEJC and can be adapted to include patients with a good performance status who are older than 75 years or have >10% pretreatment weight loss. However, the inclusion of patients with celiac nodal metastases or tumours >8 cm in length or >5 cm in width may be associated with poor outcomes." @default.
• W4281620148 created "2022-06-13" @default.
• W4281620148 creator A5007073975 @default.
• W4281620148 creator A5008288310 @default.
• W4281620148 creator A5014350537 @default.
• W4281620148 creator A5017584815 @default.
• W4281620148 creator A5021696159 @default.
• W4281620148 creator A5022449883 @default.
• W4281620148 creator A5028548681 @default.
• W4281620148 creator A5036946514 @default.
• W4281620148 creator A5047754738 @default.
• W4281620148 creator A5048152755 @default.
• W4281620148 creator A5052243751 @default.
• W4281620148 creator A5057587870 @default.
• W4281620148 creator A5059546523 @default.
• W4281620148 creator A5063784491 @default.
• W4281620148 creator A5069016257 @default.
• W4281620148 creator A5073838658 @default.
• W4281620148 creator A5075992352 @default.
• W4281620148 creator A5079909589 @default.
• W4281620148 creator A5086098617 @default.
• W4281620148 creator A5086783507 @default.
• W4281620148 date "2022-09-01" @default.
• W4281620148 modified "2023-09-27" @default.
• W4281620148 title "Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?" @default.
• W4281620148 cites W1922694287 @default.
• W4281620148 cites W1995412053 @default.
• W4281620148 cites W2015367933 @default.
• W4281620148 cites W2041560748 @default.
• W4281620148 cites W2058204273 @default.
• W4281620148 cites W2074990506 @default.
• W4281620148 cites W2089001382 @default.
• W4281620148 cites W2097784432 @default.
• W4281620148 cites W2099567806 @default.
• W4281620148 cites W2111186982 @default.
• W4281620148 cites W2113648057 @default.
• W4281620148 cites W2127996441 @default.
• W4281620148 cites W2137696504 @default.
• W4281620148 cites W2151534504 @default.
• W4281620148 cites W2154444715 @default.
• W4281620148 cites W2169906597 @default.
• W4281620148 cites W2221682152 @default.
• W4281620148 cites W2235523093 @default.
• W4281620148 cites W2306945286 @default.
• W4281620148 cites W2313229551 @default.
• W4281620148 cites W2497800384 @default.
• W4281620148 cites W2587059058 @default.
• W4281620148 cites W2621287299 @default.
• W4281620148 cites W2625564841 @default.
• W4281620148 cites W2785331147 @default.
• W4281620148 cites W3154482193 @default.
• W4281620148 doi "https://doi.org/10.1016/j.clon.2022.05.011" @default.
• W4281620148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35680509" @default.
• W4281620148 hasPublicationYear "2022" @default.
• W4281620148 type Work @default.
• W4281620148 citedByCount "2" @default.
• W4281620148 countsByYear W42816201482023 @default.
• W4281620148 crossrefType "journal-article" @default.
• W4281620148 hasAuthorship W4281620148A5007073975 @default.
• W4281620148 hasAuthorship W4281620148A5008288310 @default.
• W4281620148 hasAuthorship W4281620148A5014350537 @default.
• W4281620148 hasAuthorship W4281620148A5017584815 @default.
• W4281620148 hasAuthorship W4281620148A5021696159 @default.
• W4281620148 hasAuthorship W4281620148A5022449883 @default.
• W4281620148 hasAuthorship W4281620148A5028548681 @default.
• W4281620148 hasAuthorship W4281620148A5036946514 @default.
• W4281620148 hasAuthorship W4281620148A5047754738 @default.
• W4281620148 hasAuthorship W4281620148A5048152755 @default.
• W4281620148 hasAuthorship W4281620148A5052243751 @default.
• W4281620148 hasAuthorship W4281620148A5057587870 @default.
• W4281620148 hasAuthorship W4281620148A5059546523 @default.
• W4281620148 hasAuthorship W4281620148A5063784491 @default.
• W4281620148 hasAuthorship W4281620148A5069016257 @default.
• W4281620148 hasAuthorship W4281620148A5073838658 @default.
• W4281620148 hasAuthorship W4281620148A5075992352 @default.
• W4281620148 hasAuthorship W4281620148A5079909589 @default.
• W4281620148 hasAuthorship W4281620148A5086098617 @default.
• W4281620148 hasAuthorship W4281620148A5086783507 @default.
• W4281620148 hasConcept C121608353 @default.
• W4281620148 hasConcept C126322002 @default.
• W4281620148 hasConcept C141071460 @default.
• W4281620148 hasConcept C146357865 @default.
• W4281620148 hasConcept C151730666 @default.
• W4281620148 hasConcept C167135981 @default.
• W4281620148 hasConcept C201903717 @default.
• W4281620148 hasConcept C207103383 @default.
• W4281620148 hasConcept C2778424827 @default.
• W4281620148 hasConcept C44249647 @default.
• W4281620148 hasConcept C71924100 @default.
• W4281620148 hasConcept C72563966 @default.
• W4281620148 hasConcept C86803240 @default.
• W4281620148 hasConcept C90924648 @default.
• W4281620148 hasConceptScore W4281620148C121608353 @default.
• W4281620148 hasConceptScore W4281620148C126322002 @default.
• W4281620148 hasConceptScore W4281620148C141071460 @default.
• W4281620148 hasConceptScore W4281620148C146357865 @default.
• W4281620148 hasConceptScore W4281620148C151730666 @default.
• W4281620148 hasConceptScore W4281620148C167135981 @default.

• next